Rene Pierre Azria - Net Worth and Insider Trading

Rene Pierre Azria Net Worth

The estimated net worth of Rene Pierre Azria is at least $0 dollars as of 2024-05-02. Rene Pierre Azria is the Director of Jarden Corp and owns about 0 shares of Jarden Corp (JAH) stock worth over $0. Details can be seen in Rene Pierre Azria's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rene Pierre Azria has not made any transactions after 2011-02-22 and currently still holds the listed stock(s).

Transaction Summary of Rene Pierre Azria

Rene Pierre Azria Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rene Pierre Azria owns 3 companies in total, including Immune Pharmaceuticals Inc (IMNPQ) , Jarden Corp (JAH) , and PrimeEnergy Resources Corp (PNRG) .

Click here to see the complete history of Rene Pierre Azria’s form 4 insider trades.

Insider Ownership Summary of Rene Pierre Azria

Ticker	Comapny	Transaction Date	Type of Owner
IMNPQ	Immune Pharmaceuticals Inc	2015-09-14	director
JAH	Jarden Corp	2012-03-09	director
PNRG	PrimeEnergy Resources Corp	2010-01-01	10 percent owner

Rene Pierre Azria Latest Holdings Summary

Rene Pierre Azria currently owns a total of 1 stock. Rene Pierre Azria owns 0 shares of Jarden Corp (JAH) as of February 22, 2011, with a value of $0.

Latest Holdings of Rene Pierre Azria

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
JAH	Jarden Corp	2011-02-22	0	58.97	0

Holding Weightings of Rene Pierre Azria

Rene Pierre Azria Form 4 Trading Tracker

According to the SEC Form 4 filings, Rene Pierre Azria has made a total of 0 transactions in Jarden Corp (JAH) over the past 5 years. The most-recent trade in Jarden Corp is the sale of 1,000 shares on February 22, 2011, which brought Rene Pierre Azria around $35,400.

Insider Trading History of Rene Pierre Azria

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rene Pierre Azria Trading Performance

GuruFocus tracks the stock performance after each of Rene Pierre Azria's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rene Pierre Azria is 13.93%. GuruFocus also compares Rene Pierre Azria's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rene Pierre Azria within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rene Pierre Azria's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rene Pierre Azria

Average Return

Average return per transaction

Outperforming Transactions

3 out of 6 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	1.85
Relative Return to S&P 500(%)	4.63

Rene Pierre Azria Ownership Network

Ownership Network List of Rene Pierre Azria

No Data

Ownership Network Relation of Rene Pierre Azria

Rene Pierre Azria Owned Company Details

What does Immune Pharmaceuticals Inc do?

Who are the key executives at Immune Pharmaceuticals Inc?

Rene Pierre Azria is the director of Immune Pharmaceuticals Inc. Other key executives at Immune Pharmaceuticals Inc include director & Interim CEO Elliot M Maza , See Remarks John Militello , and director & CFO and Senior VP Robert W. Cook .

Immune Pharmaceuticals Inc (IMNPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Pharmaceuticals Inc (IMNPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Pharmaceuticals Inc (IMNPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Pharmaceuticals Inc (IMNPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Pharmaceuticals Inc Insider Transactions

No Available Data

What does Jarden Corp do?

Who are the key executives at Jarden Corp?

Rene Pierre Azria is the director of Jarden Corp. Other key executives at Jarden Corp include EVP - Operations Richard T Sansone , director & Executive Chairman Martin E Franklin , and director & Vice Chairman and President Ashken Ian G H .

Jarden Corp (JAH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jarden Corp (JAH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jarden Corp (JAH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jarden Corp (JAH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jarden Corp Insider Transactions

No Available Data

What does PrimeEnergy Resources Corp do?

Who are the key executives at PrimeEnergy Resources Corp?

Rene Pierre Azria is the 10 percent owner of PrimeEnergy Resources Corp. Other key executives at PrimeEnergy Resources Corp include 10 percent owner Rothschild Robert De , director & 10 percent owner & Chief Executive Officer Drimal Charles E Jr , and director & 10 percent owner Gaines Wehrle .

PrimeEnergy Resources Corp (PNRG) Insider Trades Summary

Over the past 18 months, Rene Pierre Azria made no insider transaction in PrimeEnergy Resources Corp (PNRG). Other recent insider transactions involving PrimeEnergy Resources Corp (PNRG) include a net sale of 79,182 shares made by Rothschild Robert De , and a net sale of 20,000 shares made by Clint Hurt .

In summary, during the past 3 months, insiders sold 46,000 shares of PrimeEnergy Resources Corp (PNRG) in total and bought 0 shares, with a net sale of 46,000 shares. During the past 18 months, 99,182 shares of PrimeEnergy Resources Corp (PNRG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 99,182 shares.

PrimeEnergy Resources Corp (PNRG)'s detailed insider trading history can be found in Insider Trading Tracker table.

PrimeEnergy Resources Corp Insider Transactions

No Available Data

Rene Pierre Azria Mailing Address

Above is the net worth, insider trading, and ownership report for Rene Pierre Azria. You might contact Rene Pierre Azria via mailing address: C/o Jarden Corp, 555 Theodore Fremd Ave, Rye Ny 10580.

Discussions on Rene Pierre Azria

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.